Livzon Pharmaceutical Group Inc. (SHE:000513)
China flag China · Delayed Price · Currency is CNY
32.67
+0.13 (0.40%)
Apr 28, 2026, 3:04 PM CST

SHE:000513 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Cash & Equivalents
8,8869,30510,82711,32610,4119,146
Short-Term Investments
374.08270.56----
Trading Asset Securities
707.991,34589.3681.79108.09182.77
Cash & Short-Term Investments
9,96810,92110,91711,40810,5199,329
Cash Growth
-8.55%0.04%-4.30%8.44%12.76%-6.52%
Accounts Receivable
3,2843,3863,2493,5754,0393,294
Other Receivables
42.4390.7859.2851.9131.3264.37
Receivables
3,3263,4773,3083,6274,0713,358
Inventory
1,5281,5611,9982,0612,0451,663
Other Current Assets
839.14159.53197.44171.11352322.42
Total Current Assets
15,66116,11816,42017,26616,98714,673
Property, Plant & Equipment
4,2694,3224,5374,5664,5924,239
Long-Term Investments
2,5171,9162,0851,6701,7381,695
Goodwill
124.91124.91124.91124.91103.04103.04
Other Intangible Assets
458.88468.85403.68426.28557.44260.28
Long-Term Deferred Tax Assets
414.24427.72356.35301.92283.89252.69
Long-Term Deferred Charges
529.73524.74396.25468.62416.74704.41
Other Long-Term Assets
218.8284.09132.55221.17189.66444.62
Total Assets
24,19423,98524,45625,04524,86822,372
Accounts Payable
1,3251,3181,5841,6581,8621,817
Accrued Expenses
142.293,2413,1093,2953,2492,656
Short-Term Debt
2,7172,1202,4551,8601,6222,043
Current Portion of Long-Term Debt
72.64157.8936.21647.47--
Current Portion of Leases
-15.3312.5312.210.449.28
Current Income Taxes Payable
226.1682.43112.88181.5892.5797.45
Current Unearned Revenue
74.58104.38124.63138226.19167.8
Other Current Liabilities
3,430180.71191.27294.49334.42134.34
Total Current Liabilities
7,9887,2207,6258,0877,3976,925
Long-Term Debt
158.01749.361,4661,6131,974636.78
Long-Term Leases
17.8217.3213.19.0311.615.27
Long-Term Unearned Revenue
236.39242.16238.42269.37273.21258.88
Long-Term Deferred Tax Liabilities
210.3210.28207.39209.81191.96156.89
Other Long-Term Liabilities
--0.5-908478
Total Liabilities
8,6108,4389,55010,2789,9328,061
Common Stock
887.91887.91911.35923.94935.55937.87
Additional Paid-In Capital
349.55-257.851,3221,4221,629
Retained Earnings
13,31512,73812,50611,65311,18210,461
Treasury Stock
---196.62--55.94-71.21
Comprehensive Income & Other
-43.43262.25383.57143.07391.6446.55
Total Common Equity
14,50913,88813,86214,04213,87613,004
Minority Interest
1,0741,6591,043724.211,0601,307
Shareholders' Equity
15,58415,54714,90614,76714,93614,311
Total Liabilities & Equity
24,19423,98524,45625,04524,86822,372
Total Debt
2,9663,0603,9834,1413,6192,694
Net Cash (Debt)
7,0027,8616,9347,2666,9016,635
Net Cash Growth
-0.57%13.37%-4.57%5.29%4.01%-17.58%
Net Cash Per Share
7.868.807.537.817.377.09
Filing Date Shares Outstanding
887.91887.91908.91923.94932.23929.97
Total Common Shares Outstanding
887.91887.91908.91923.94932.23929.97
Working Capital
7,6738,8988,7959,1799,5917,748
Book Value Per Share
16.3415.6415.2515.2014.8813.98
Tangible Book Value
13,92513,29513,33413,49113,21612,640
Tangible Book Value Per Share
15.6814.9714.6714.6014.1813.59
Buildings
---3,745-3,123
Machinery
-8,9868,7294,5517,5773,764
Construction In Progress
-234.18257.37289.31602.44554.58
Source: S&P Global Market Intelligence. Standard template. Financial Sources.